SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-008082
Filing Date
2019-08-13
Accepted
2019-08-13 17:16:12
Documents
67
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q morf-20190630x10q.htm 10-Q 2418573
2 EX-3.1 morf-20190630ex3180232b9.htm EX-3.1 48982
3 EX-3.2 morf-20190630ex3279254aa.htm EX-3.2 222327
4 EX-31.1 morf-20190630ex3114ee4b7.htm EX-31.1 13793
5 EX-31.2 morf-20190630ex31289c95d.htm EX-31.2 13681
6 EX-32.1 morf-20190630ex321283af0.htm EX-32.1 7842
7 EX-32.2 morf-20190630ex322edd7d4.htm EX-32.2 7727
  Complete submission text file 0001558370-19-008082.txt   7042188

Data Files

Seq Description Document Type Size
8 EX-101.INS morf-20190630.xml EX-101.INS 1185361
9 EX-101.SCH morf-20190630.xsd EX-101.SCH 41831
10 EX-101.CAL morf-20190630_cal.xml EX-101.CAL 46095
11 EX-101.DEF morf-20190630_def.xml EX-101.DEF 188817
12 EX-101.LAB morf-20190630_lab.xml EX-101.LAB 405013
13 EX-101.PRE morf-20190630_pre.xml EX-101.PRE 328795
Mailing Address 35 GATEHOUSE DRIVE A2 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE A2 WALTHAM MA 02451 9787296480
Morphic Holding, Inc. (Filer) CIK: 0001679363 (see all company filings)

IRS No.: 473878772 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38940 | Film No.: 191021747
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1